Oil & Gas Midstream
Compare Stocks
3 / 10Stock Comparison
RBNE vs GEVO vs AMTX
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Oil & Gas Refining & Marketing
RBNE vs GEVO vs AMTX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Oil & Gas Midstream | Chemicals - Specialty | Oil & Gas Refining & Marketing |
| Market Cap | $4M | $493M | $213M |
| Revenue (TTM) | $7M | $174M | $209M |
| Net Income (TTM) | $1M | $-11M | $-74M |
| Gross Margin | 78.1% | 23.4% | 3.4% |
| Operating Margin | 15.8% | -4.6% | -13.4% |
| Forward P/E | 3.2x | — | — |
| Total Debt | $0.00 | $168M | $318M |
| Cash & Equiv. | $369.00 | $1M | $5M |
RBNE vs GEVO vs AMTX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 25 | May 26 | Return |
|---|---|---|---|
| Robin Energy Ltd. (RBNE) | 100 | 51.8 | -48.2% |
| Gevo, Inc. (GEVO) | 100 | 184.5 | +84.5% |
| Aemetis, Inc. (AMTX) | 100 | 247.6 | +147.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RBNE vs GEVO vs AMTX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RBNE has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- 15.5% margin vs AMTX's -35.4%
- 4.3% ROA vs AMTX's -29.3%, ROIC 3.3% vs -70.3%
GEVO is the clearest fit if your priority is growth exposure.
- Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
- 8.5% revenue growth vs RBNE's -56.6%
AMTX is the clearest fit if your priority is income & stability and long-term compounding.
- beta 1.46
- 31.1% 10Y total return vs GEVO's -98.6%
- Lower volatility, beta 1.46, current ratio 0.07x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs RBNE's -56.6% | |
| Quality / Margins | 15.5% margin vs AMTX's -35.4% | |
| Stability / Safety | Beta 1.46 vs GEVO's 1.64 | |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | +140.0% vs RBNE's -40.8% | |
| Efficiency (ROA) | 4.3% ROA vs AMTX's -29.3%, ROIC 3.3% vs -70.3% |
RBNE vs GEVO vs AMTX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
RBNE vs GEVO vs AMTX — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RBNE leads in 3 of 6 categories
GEVO leads 0 • AMTX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RBNE leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMTX is the larger business by revenue, generating $209M annually — 30.9x RBNE's $7M. RBNE is the more profitable business, keeping 15.5% of every revenue dollar as net income compared to AMTX's -35.4%. On growth, RBNE holds the edge at +151.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $7M | $174M | $209M |
| EBITDAEarnings before interest/tax | — | $18M | -$21M |
| Net IncomeAfter-tax profit | — | -$11M | -$74M |
| Free Cash FlowCash after capex | — | -$35M | -$38M |
| Gross MarginGross profit ÷ Revenue | +78.1% | +23.4% | +3.4% |
| Operating MarginEBIT ÷ Revenue | +15.8% | -4.6% | -13.4% |
| Net MarginNet income ÷ Revenue | +15.5% | -6.6% | -35.4% |
| FCF MarginFCF ÷ Revenue | +100.8% | -19.9% | -18.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +151.6% | +47.5% | +27.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +118.5% | +3.8% | +29.8% |
Valuation Metrics
RBNE leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, RBNE's 1.8x EV/EBITDA is more attractive than GEVO's 102.1x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $4M | $493M | $213M |
| Enterprise ValueMkt cap + debt − cash | $4M | $659M | $526M |
| Trailing P/EPrice ÷ TTM EPS | 3.20x | -14.50x | -2.44x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | 1.77x | 102.12x | — |
| Price / SalesMarket cap ÷ Revenue | 0.58x | 3.07x | 1.02x |
| Price / BookPrice ÷ Book value/share | 0.16x | 1.01x | — |
| Price / FCFMarket cap ÷ FCF | 0.58x | — | — |
Profitability & Efficiency
RBNE leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
RBNE delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-2 for GEVO. On the Piotroski fundamental quality scale (0–9), RBNE scores 5/9 vs AMTX's 4/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +4.4% | -2.4% | — |
| ROA (TTM)Return on assets | +4.3% | -1.7% | -29.3% |
| ROICReturn on invested capital | +3.3% | -2.8% | -70.3% |
| ROCEReturn on capital employed | +4.4% | -3.1% | -19.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 4 |
| Debt / EquityFinancial leverage | — | 0.36x | — |
| Net DebtTotal debt minus cash | -$369 | $166M | $313M |
| Cash & Equiv.Liquid assets | $369 | $1M | $5M |
| Total DebtShort + long-term debt | $0 | $168M | $318M |
| Interest CoverageEBIT ÷ Interest expense | 81.61x | -0.04x | -0.27x |
Total Returns (Dividends Reinvested)
Evenly matched — GEVO and AMTX each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEVO five years ago would be worth $3,476 today (with dividends reinvested), compared to $1,659 for RBNE. Over the past 12 months, AMTX leads with a +140.0% total return vs RBNE's -40.8%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs RBNE's -45.1% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -55.7% | -1.5% | +96.2% |
| 1-Year ReturnPast 12 months | -40.8% | +88.0% | +140.0% |
| 3-Year ReturnCumulative with dividends | -83.4% | +65.0% | +37.4% |
| 5-Year ReturnCumulative with dividends | -83.4% | -65.2% | -76.1% |
| 10-Year ReturnCumulative with dividends | -83.4% | -98.6% | +31.1% |
| CAGR (3Y)Annualised 3-year return | -45.1% | +18.2% | +11.2% |
Risk & Volatility
Evenly matched — RBNE and AMTX each lead in 1 of 2 comparable metrics.
Risk & Volatility
RBNE is the less volatile stock with a -0.29 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMTX currently trades 82.1% from its 52-week high vs RBNE's 6.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.29x | 1.64x | 1.46x |
| 52-Week HighHighest price in past year | $20.57 | $2.97 | $3.80 |
| 52-Week LowLowest price in past year | $0.67 | $1.01 | $1.22 |
| % of 52W HighCurrent price vs 52-week peak | +6.9% | +68.4% | +82.1% |
| RSI (14)Momentum oscillator 0–100 | 33.1 | 53.5 | 58.2 |
| Avg Volume (50D)Average daily shares traded | 6.6M | 4.5M | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: GEVO as "Buy", AMTX as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs -43.9% for AMTX (target: $2).
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | $3.50 | $1.75 |
| # AnalystsCovering analysts | — | 14 | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% |
RBNE leads in 3 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
RBNE vs GEVO vs AMTX: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is RBNE or GEVO or AMTX a better buy right now?
For growth investors, Gevo, Inc.
(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus -56. 6% for Robin Energy Ltd. (RBNE). Robin Energy Ltd. (RBNE) offers the better valuation at 3. 2x trailing P/E, making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — RBNE or GEVO or AMTX?
Over the past 5 years, Gevo, Inc.
(GEVO) delivered a total return of -65. 2%, compared to -83. 4% for Robin Energy Ltd. (RBNE). Over 10 years, the gap is even starker: AMTX returned +31. 1% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — RBNE or GEVO or AMTX?
By beta (market sensitivity over 5 years), Robin Energy Ltd.
(RBNE) is the lower-risk stock at -0. 29β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately -671% more volatile than RBNE relative to the S&P 500.
04Which is growing faster — RBNE or GEVO or AMTX?
By revenue growth (latest reported year), Gevo, Inc.
(GEVO) is pulling ahead at 849. 3% versus -56. 6% for Robin Energy Ltd. (RBNE). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to -93. 2% for Robin Energy Ltd.. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — RBNE or GEVO or AMTX?
Robin Energy Ltd.
(RBNE) is the more profitable company, earning 15. 5% net margin versus -37. 0% for Aemetis, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RBNE leads at 15. 8% versus -17. 9% for AMTX. At the gross margin level — before operating expenses — RBNE leads at 78. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — RBNE or GEVO or AMTX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is RBNE or GEVO or AMTX better for a retirement portfolio?
For long-horizon retirement investors, Robin Energy Ltd.
(RBNE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 29)). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RBNE: -83. 4%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between RBNE and GEVO and AMTX?
These companies operate in different sectors (RBNE (Energy) and GEVO (Basic Materials) and AMTX (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RBNE is a small-cap deep-value stock; GEVO is a small-cap high-growth stock; AMTX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.